FTSE Index shares to watch next week: BT, BP, IAG, AstraZeneca, Marks & Spencer

The FTSE 100 Index has reached a record high of £9,760, up 30% from its year-low, driven by strong earnings reports. Next week, major constituents including BP, Marks & Spencer, BT Group, and AstraZeneca will release financial results, with BP under pressure from Elliott Management regarding its strategy, M&S reporting strong profit growth in food sales, and AstraZeneca benefiting from recent drug approvals and trial successes. Concurrently, the market will be watching the Bank of England's interest rate decision, which is anticipated to maintain current rates despite persistent inflation.

Analysis

The FTSE 100 Index has achieved a record high of £9,760, marking a 30% increase from its year-low, largely driven by robust earnings reports from companies such as Shell and Standard Chartered. The upcoming week is critical, featuring financial results from major constituents including BP, Marks & Spencer, BT Group, and AstraZeneca, alongside the Bank of England's pivotal interest rate decision. This confluence of corporate and macroeconomic events will provide significant market direction.

BP, having seen its stock rebound over 40% this year, faces considerable institutional pressure from Elliott Management to intensify its focus on fossil fuels, a strategy that contrasts with rival Shell's recent $3.5 billion share repurchase program. Marks & Spencer reported a 22% rise in profit before tax to £875 million for the last financial year, primarily fueled by an 8.7% growth in food sales, though statutory profit was impacted by a non-cash charge related to its Ocado investment.

AstraZeneca's stock has performed strongly, jumping 31% from its May low, bolstered by recent drug approvals like Tezspire and Koselugo, and positive trial results for Gefurulimab in Myasthenia Gravis. Conversely, BT Group's share price has experienced a 16% pullback from its year-high, with analyst consensus forecasting a 2.2% year-over-year revenue decline to £4.9 billion, raising concerns about its capital expenditure and future growth trajectory.

The Bank of England is widely anticipated to maintain current interest rates, despite persistent inflation, which could influence broader market sentiment and consumer spending. This macroeconomic backdrop, combined with diverse corporate performance, suggests a nuanced outlook for the FTSE 100, where company-specific fundamentals and strategic responses to market pressures will be key determinants of investor returns.

Key Decisions for Investors

• Closely monitor upcoming earnings reports from FTSE 100 constituents like BP, M&S, BT Group, and AstraZeneca for confirmation of current market sentiment and future guidance.
• Evaluate BP's strategic response to Elliott Management's demands and its capital allocation decisions, particularly in light of declining energy prices and Shell's robust share repurchase program.
• Assess the implications of the Bank of England's unchanged interest rate decision on the UK economy and consumer-facing sectors, while scrutinizing M&S's ability to sustain food sales growth amidst broader economic slowdowns.
• Scrutinize BT Group's financial results for clarity on its capital expenditure and revenue outlook, given the recent stock pullback and projected revenue decline.